Alaunos Therapeutics (TCRT) Institutional Ownership → He Is Giving Away Bitcoin (From Crypto Swap Profits) (Ad) Free TCRT Stock Alerts $1.29 -0.01 (-0.77%) (As of 05/8/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Alaunos Therapeutics (NASDAQ:TCRT)CurrentInstitutional OwnershipPercentage27.72%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$1.45MNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$8.77M Get TCRT Insider Trade Alerts Want to know when executives and insiders are buying or selling Alaunos Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data TCRT Institutional Buying and Selling by Quarter Ad Priority GoldThe 2024 Gold Rush: Unleashing Market PotentialWelcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights.Get your free information kit NOW, before it's too late. Alaunos Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/2/2024 Magnolia Capital Advisors LLC24,695$45K0.0%-93.8%0.154% 4/30/2024 Fortis Group Advisors LLC13,999$25K0.0%N/A0.087% 2/20/2024MSD Partners L.P.15,151,516$1.07M0.1%-33.3%94.402% 2/9/2024 Commerce Bank437,000$31K0.0%-4.8%2.723% 2/2/2024 Magnolia Capital Advisors LLC401,507$28K0.0%-7.3%0.167% 11/4/2023 Magnolia Capital Advisors LLC432,969$56K0.1%N/A0.180% Get the Latest News and Ratings for TCRT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Alaunos Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 7/20/2023 Allred Capital Management LLC253,000$129K0.1%+24.6%0.105% 5/12/2023CIBC Private Wealth Group LLC50,400$32K0.0%+65.8%0.021% 4/21/2023Chiron Capital Management LLC81,830$52K0.0%-22.7%0.034% 2/15/2023 Allred Capital Management LLC193,000$125K0.1%+22.2%0.089% 2/14/2023Discovery Capital Management LLC CT16,185,998$10.51M1.5%+10.5%7.487% 2/13/2023 GSA Capital Partners LLP957,348$621K0.1%+57.4%0.443% 1/30/2023 Welch Group LLC43,000$28K0.0%-26.7%0.020% 1/9/2023Addison Capital Co15,870$2.32M1.5%N/A0.007% 11/15/2022Laurion Capital Management LP4,220,500$7.26M0.0%-1.6%1.952% 11/15/2022 Magnolia Capital Advisors LLC418,569$720K0.6%+25.1%0.194% 11/15/2022Boxer Capital LLC1,500,000$2.58M0.1%N/A0.694% 11/15/2022Caxton Associates LP311,974$537K0.1%+209.8%0.144% 11/14/2022Zacks Investment Management44,550$77K0.0%N/A0.021% 11/14/2022Tudor Investment Corp Et Al39,374$68K0.0%-88.1%0.018% 11/14/2022Cubist Systematic Strategies LLC349,867$602K0.0%+4,589.3%0.162% 11/14/2022Ergoteles LLC485,434$835K0.0%-48.2%0.225% 11/14/2022E Fund Management Co. Ltd.15,167$26K0.0%N/A0.007% 11/7/2022Virtu Financial LLC74,592$128K0.0%N/A0.035% 11/3/2022 Mutual Advisors LLC22,095$38K0.0%-40.4%0.010% 11/3/2022Barclays PLC136,136$234K0.0%N/A0.063% 10/31/2022Concorde Asset Management LLC35,500$61K0.1%N/A0.016% 10/31/2022Green Square Capital Advisors LLC1,080,000$1.86M0.3%N/A0.500% 10/26/2022Belvedere Trading LLC66,493$78K0.0%N/A0.031% 10/24/2022 ACT Wealth Management LLC38,476$66K0.0%N/A0.018% 10/17/2022SevenBridge Financial Group LLC20,000$34K0.0%N/A0.009% 10/14/2022 Private Advisor Group LLC119,374$206K0.0%N/A0.055% 10/13/2022Chiron Capital Management LLC116,860$201K0.1%N/A0.054% 10/13/2022 Welch Group LLC58,700$101K0.0%N/A0.027% 10/11/2022 Sugarloaf Wealth Management LLC79,050$136K0.0%N/A0.037% 10/4/2022 AdvisorNet Financial Inc42,329$73K0.0%N/A0.020% 8/16/2022Discovery Capital Management LLC CT14,125,079$17.52M2.3%N/A6.541% 8/15/2022Laurion Capital Management LP4,289,193$5.32M0.1%N/A1.986% 8/15/2022Kettle Hill Capital Management LLC344,400$427K0.1%N/A0.159% 8/12/2022 Commerce Bank459,000$569K0.0%N/A0.213% Tech GIANT’s Plans to Revolutionize Crypto… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now.8/10/2022Synovus Financial Corp33,000$41K0.0%N/A0.015% 8/8/2022Nicolet Advisory Services LLC21,500$30K0.0%N/A0.010% 8/8/2022 Oppenheimer & Co. Inc.45,500$56K0.0%N/A0.021% 8/8/2022Y Intercept Hong Kong Ltd25,079$31K0.0%N/A0.012% 8/5/2022Gamble Jones Investment Counsel61,000$76K0.0%N/A0.028% 8/5/2022Horizon Kinetics Asset Management LLC34,000$42K0.0%N/A0.016% 8/4/2022Steward Partners Investment Advisory LLC36,106$45K0.0%N/A0.017% 8/3/2022CIBC Private Wealth Group LLC41,490$51K0.0%N/A0.019% 8/3/2022Stephens Inc. AR25,162$31K0.0%N/A0.012% 8/3/2022 Janney Montgomery Scott LLC82,412$101K0.0%N/A0.038% (Data available from 1/1/2016 forward) TCRT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TCRT shares? During the previous two years, 40 institutional investors and hedge funds held shares of Alaunos Therapeutics. The most heavily invested institutionals were Discovery Capital Management LLC CT ($10.51M), Laurion Capital Management LP ($7.26M), Boxer Capital LLC ($2.58M), Addison Capital Co ($2.32M), Green Square Capital Advisors LLC ($1.86M), MSD Partners L.P. ($1.07M), and Ergoteles LLC ($835K).Learn more on TCRT's institutional investors. What percentage of Alaunos Therapeutics stock is owned by institutional investors? 27.72% of Alaunos Therapeutics stock is owned by institutional investors. Learn more on TCRT's institutional investor holdings. Which institutional investors have been buying Alaunos Therapeutics stock? Of the 36 institutional investors that purchased Alaunos Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Discovery Capital Management LLC CT ($15.67M), Laurion Capital Management LP ($4.29M), Boxer Capital LLC ($1.50M), Green Square Capital Advisors LLC ($1.08M), Magnolia Capital Advisors LLC ($516.88K), Commerce Bank ($459K), and GSA Capital Partners LLP ($349.31K). How much institutional buying is happening at Alaunos Therapeutics? Institutional investors have bought a total of 26,147,914 shares in the last 24 months. This purchase volume represents approximately $490.23M in transactions. Which Alaunos Therapeutics major shareholders have been selling company stock? Of the 9 institutional investors that sold Alaunos Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: MSD Partners L.P. ($7.58M), Ergoteles LLC ($451.47K), Magnolia Capital Advisors LLC ($408.27K), Tudor Investment Corp Et Al ($292.03K), Laurion Capital Management LP ($68.69K), Chiron Capital Management LLC ($24.06K), and Commerce Bank ($22K). How much institutional selling is happening at Alaunos Therapeutics? Institutional investors have sold a total of 8,872,978 shares in the last 24 months. This volume of shares sold represents approximately $30.49M in transactions. Related Companies: MEI Pharma Major Shareholders Sol-Gel Technologies Major Shareholders Benitec Biopharma Major Shareholders Synlogic Major Shareholders RenovoRx Major Shareholders GlycoMimetics Major Shareholders KALA BIO Major Shareholders BioVie Major Shareholders Galecto Major Shareholders Flora Growth Major Shareholders This page (NASDAQ:TCRT) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsUrgent Nvidia WarningAltimetry348 million Americans lives to END as we know it?The Oxford ClubThe A.I. story nobody is telling you (Read ASAP)TradeSmithGold Set to EXPLODE!Gold Safe Exchange Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alaunos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.